Australia's largest stock trading and investment forum Australia's #1 stock forum

KZA

Click for more information

0.00%

8.0¢ kazia therapeutics limited

Share price, page-50

First 50 Last

Share
Profile

Follow
RBx

643 Posts.

1002

26/06/18

11:06

Post #: 33949266
Share

Originally posted by harvett ↑

NRT was the biggest bulls*& company out. Telling investors of start dates for clinical trials when Anisina had not even started toxicity testing. And cantrixil they had not even and ind and they were handing out dates like fairy flosses. And investor wonder why our current management is so coy. OMG.........

"The study results have led Novogen stock to have a stunning start to the year, with shares in the group rising over 180 per cent over the first 3 months of 2015 to today.
Human trials of Cantrixil are expected to start in late 2015, and the study will mainly target ovarian cancer and colo-rectal cancer.
Novogen said its Anisina drug is being brought into the clinic in early 2016 for the treatment of late-stage melanoma and prostate cancer.
"https://www.theaustralian.com.au/bu...y/news-story/54de03a413c6a6da25fcca6073c7d6cb

Expand

Harvett,

Why would Cantrixil have needed an IND to start clinical trials? Please THINK before you go on another rant.

KZA Price at posting: 43.0¢ Sentiment: None Disclosure: Held
4 Upvote

0 Great analysis

Reply

Top Stories

FRB

Firebird snaffles Environmental Permit for Jinshi plant

FBR

FBR's robotic home construction tech passes first US early-stage structural compliance check

GL1

Global Lithium latest hit by lithium downturn; shares fall -10% as Manna DFS paused

SDF

Steadfast Group sees $600M wiped off on resumed trades after Four Corners feature

DUR

Duratec snags $76.5M in works from Woodside and Defence respectively - including spy network upgrade

There are more pages in this discussion • 30 more messages in this thread...

First 50 Last

Add KZA (ASX) to my watchlist